ABSTRACT
A ureterocele is a rare congenital anomaly with cystic dilation of the terminal segment of the ureter entirely within the bladder (orthotopic) or associated with ectopic ureter (ectopic). Its aetiology has not been fully clarified; however, it may involve genetic or acquired factors. Urothelial carcinoma (UC) is the most common type of canine urinary tract neoplasm, among which over 90% of cases are invasive. The non-papillary (flat) non-infiltrating form accounts for a very small percentage of canine UCs and is considered carcinoma in situ (CIS). The neoplastic cells of CIS remain within the ureteral mucosa and do not breach the basement membrane. UCs originating from the canine ureter are extremely rare, and no report of a ureteral UC concurrently occurring with a ureterocele has been reported. A 7-year-old castrated male Maltese dog weighing 3.5 kg was referred with a 2-week history of lethargy, anorexia, pollakiuria and intermittent panting. The dog underwent open surgery for removal of bladder calculi 2 years prior, and at the time of the surgery, no other urinary system abnormalities were identified. Ultrasonographic and computed tomographic scans revealed a severely enlarged right kidney and ureter with a ureterocele on the ipsilateral side. A diagnosis of an orthotopic ureterocele causing hydronephrosis and hydroureter was established. Complete nephroureterectomy and ureterocelectomy using the marsupialisation technique were performed. The postoperative histological examination of the excised tissues showed a multifocal carcinoma in situ (non-papillary non-infiltrating UC) in the proximal ureter and a fluid-filled kidney with a thin rim of fibrotic renal tissue. No neoplastic changes were observed in the ureterocele tissue. Postoperatively, the dog recovered rapidly without complications except temporary urinary incontinence, and no evidence of tumour recurrence was detected by ultrasonography performed 6 months after surgery. This case report describes the first case of a dog with an orthotopic ureterocele and ureteral UC, which occurred concurrently at the ipsilateral side of the ureter. The condition was successfully managed with a nephroureterectomy and partial ureterocelectomy.
Subject(s)
Carcinoma in Situ , Carcinoma, Transitional Cell , Dog Diseases , Ureterocele , Urinary Bladder Neoplasms , Animals , Carcinoma in Situ/complications , Carcinoma in Situ/veterinary , Carcinoma, Transitional Cell/complications , Carcinoma, Transitional Cell/surgery , Carcinoma, Transitional Cell/veterinary , Dog Diseases/diagnosis , Dog Diseases/surgery , Dogs , Male , Neoplasm Recurrence, Local/complications , Neoplasm Recurrence, Local/veterinary , Ureterocele/complications , Ureterocele/diagnosis , Ureterocele/surgery , Ureterocele/veterinary , Urinary Bladder Neoplasms/complications , Urinary Bladder Neoplasms/surgery , Urinary Bladder Neoplasms/veterinaryABSTRACT
Carcinoma in situ of the breast is a well-known entity in humans. In veterinary medicine, particularly in canine and feline mammary literature, there is no agreement whether the term in situ should be used to indicate a specific carcinoma histotype or the noninvasive status of a carcinoma of any histotype. Moreover, in the most recent histologic classification of mammary tumors published by the Davis-Thompson Foundation, it is suggested to abandon the term carcinoma in situ given the lack of standardized criteria defining this entity, replacing it with epitheliosis or ductal/lobular hyperplasia with severe atypia. This publication presents a critical review of the term in situ in human and veterinary medicine considering the evolution of the term over the years and its heterogeneous use by different authors, including variations in immunohistochemical markers for classification. This review aims to point out the lack of uniformity in the nomenclature and classification issues in veterinary medicine regarding the use of the term in situ, laying the ground for a process of standardization in future publications.
Subject(s)
Breast Neoplasms , Carcinoma in Situ , Carcinoma, Intraductal, Noninfiltrating , Carcinoma, Lobular , Cat Diseases , Dog Diseases , Animals , Breast Neoplasms/veterinary , Carcinoma in Situ/pathology , Carcinoma in Situ/veterinary , Carcinoma, Intraductal, Noninfiltrating/pathology , Carcinoma, Intraductal, Noninfiltrating/veterinary , Carcinoma, Lobular/pathology , Carcinoma, Lobular/veterinary , Cats , Dogs , Female , Humans , Hyperplasia/veterinaryABSTRACT
Oral squamous cell carcinomas (OSCCs) are common cancers of cats. While papillomaviruses (PVs) are an important cause of human OSCCs, there is currently little evidence that PVs cause squamous cell carcinomas (SCCs) of the mouth or other mucosal surfaces in cats. In the present cat, in situ carcinomas developed on the gingiva and nictitating membrane. Neoplastic cells within both cancers contained prominent PV-induced cellular changes consistent with those caused by Felis catus PV3 (FcaPV3), and FcaPV3 DNA was amplified from both cancers. Neoplasms also contained intense nuclear and cytoplasmic p16CDKN2A protein (p16) immunolabeling, suggesting PV-induced degradation of retinoblastoma protein. The molecular and histological features strongly suggested the cancers were caused by FcaPV3 infection. This is the first report of an association between PV infection and the development of an in situ carcinoma of the mucosa of cats. The identification of these lesions suggests that PVs might cause a proportion of OSCCs, and SCCs from other mucosal surfaces, in cats.
Subject(s)
Carcinoma in Situ , Carcinoma, Squamous Cell , Cat Diseases , Mouth Neoplasms , Papillomavirus Infections , Animals , Carcinoma in Situ/veterinary , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/veterinary , Cats , DNA, Viral/genetics , Gingiva/metabolism , Gingiva/pathology , Mouth Neoplasms/veterinary , Nictitating Membrane/pathology , Papillomaviridae/genetics , Papillomavirus Infections/complications , Papillomavirus Infections/veterinaryABSTRACT
Numerous raised plaques were observed on the feet of a red-billed gull (Chroicocephalus novaehollandiae scopulinus) that had been found dead. The plaques consisted of thickened epidermis with cell changes indicative of papillomavirus (PV) infection prominent within affected areas. Evidence suggesting progression to neoplasia was visible in one lesion. A DNA sequence that was most similar, but only 68.3% identical, to duck PV type 3 was amplified from the papillomas, suggesting a novel PV type. Lesions containing PV DNA have only previously been reported in three avian species. This is the first evidence that PVs could cause neoplasia in birds.
Subject(s)
Bird Diseases/virology , Carcinoma in Situ/veterinary , Charadriiformes/virology , Papilloma/veterinary , Papillomaviridae/isolation & purification , Papillomavirus Infections/veterinary , Animals , Bird Diseases/pathology , Capsid Proteins/genetics , Carcinoma in Situ/pathology , Carcinoma in Situ/virology , DNA, Viral/genetics , Foot/pathology , Foot/virology , Papilloma/pathology , Papilloma/virology , Papillomaviridae/classification , Papillomaviridae/genetics , Papillomavirus Infections/pathology , Papillomavirus Infections/virology , PhylogenyABSTRACT
Ovarian cancer is the fifth cause of cancer-related mortality in women, with an expected 5-year survival rate of only 47%. High-grade serous carcinoma (HGSC), an epithelial cancer phenotype, is the most common malignant ovarian cancer. It is known that the precursors of HGSC originate from secretory epithelial cells within the Fallopian tube, which first develops as serous tubal intraepithelial carcinoma (STIC). Here, we used gene editing by CRISPR-Cas9 to knock out the oncogene p53 in dog oviductal epithelia cultured in a dynamic microfluidic chip to create an in vitro model that recapitulated human STIC. Similar to human STIC, the gene-edited oviduct-on-a-chip, exhibited loss of cell polarization and had reduced ciliation, increased cell atypia and proliferation, with multilayered epithelium, increased Ki67, PAX8 and Myc and decreased PTEN and RB1 mRNA expression. This study provides a biomimetic in vitro model to study STIC progression and to identify potential biomarkers for early detection of HGSC.
Subject(s)
Carcinoma in Situ/veterinary , Dog Diseases/metabolism , Lab-On-A-Chip Devices/veterinary , Ovarian Neoplasms/veterinary , Oviducts/metabolism , Animals , CRISPR-Associated Protein 9 , CRISPR-Cas Systems , Carcinoma in Situ/metabolism , Dogs , Female , Fluorescent Antibody Technique , Gene Editing , Ovarian Neoplasms/metabolism , Polymerase Chain ReactionABSTRACT
Several studies based on histopathology or molecular investigations suggest a causal relation between Felis catus papillomavirus (FcaPV-2) infection and bowenoid in situ carcinoma (BISC) in cats. Nevertheless, data on distribution of viral DNA for different F. catus papillomavirus types (FcaPV-1, 2, 3, 4, 5) in precancerous skin lesions are lacking. In this study, incisional and excisional skin biopsies from 18 cats with BISC were investigated for the presence of FcaPV DNA by quantitative polymerase chain reaction (qPCR) and chromogenic in situ hybridization (CISH) using specific probes to detect each of the FcaPVs that have been identified so far. By qPCR analysis, 15 of 18 samples were positive for FcaPV-2, 2 were positive for FcaPV-4, and 1 sample was negative for all FcaPVs studied. Two cases were positive for FcaPV-5 by qPCR only. FcaPV-1 and FcaPV-3 were not detected by either method. CISH positivity for FcaPV-2 and FcaPV-4 was 100% concordant with qPCR. FcaPV-2 CISH signal was observed as nuclear dots within grouped neoplastic keratinocytes in 12 BISCs and in the perilesional skin of 9 biopsies. In 3 of these 9 cases, the signal was not observed within the BISC. FcaPV-4 CISH positivity was detected only within BISCs in 2 cases. The overall rate of concordance for FcaPV detection between PCR and CISH was 97.8%. This study suggests that CISH is a reliable method to detect FcaPV-2 and FcaPV-4 infection in cats and provides useful information on the type, rate, and localization of infected cells.
Subject(s)
Carcinoma in Situ/veterinary , Cat Diseases/diagnosis , In Situ Hybridization/veterinary , Papillomaviridae/isolation & purification , Papillomavirus Infections/veterinary , Animals , Carcinoma in Situ/diagnosis , Carcinoma in Situ/pathology , Carcinoma in Situ/virology , Cat Diseases/pathology , Cat Diseases/virology , Cats , Chromogenic Compounds , DNA Probes , DNA, Viral/genetics , Feasibility Studies , Papillomaviridae/genetics , Papillomavirus Infections/diagnosis , Papillomavirus Infections/pathology , Papillomavirus Infections/virology , Polymerase Chain Reaction/veterinary , Sensitivity and Specificity , Skin/pathologyABSTRACT
A 10-y-old Irish Setter was presented with a history of recurrent episodes of regurgitation and vomiting, with more recent development of tachypnea. Megaesophagus had been diagnosed in the dog 2 y prior to this presentation. A solitary polypoid mass present immediately rostral to the lower esophageal sphincter was biopsied during percutaneous endoscopic gastrostomy tube placement. Barrett esophagus was diagnosed based on the observation of a polypoid mass with intestinal metaplasia that arose from the surrounding esophagus. Histology of the polypoid mass demonstrated squamous-to-columnar metaplasia, hyperplasia, dysplasia, and carcinoma in situ.
Subject(s)
Barrett Esophagus/veterinary , Carcinoma in Situ/veterinary , Dog Diseases/diagnosis , Esophageal Neoplasms/veterinary , Gastroesophageal Reflux/veterinary , Neoplasms, Multiple Primary/veterinary , Animals , Barrett Esophagus/diagnosis , Biopsy/veterinary , Carcinoma in Situ/diagnosis , Diagnosis, Differential , Dog Diseases/pathology , Dogs , Esophageal Neoplasms/diagnosis , Fatal Outcome , Male , Neoplasms, Multiple Primary/diagnosisSubject(s)
Adenocarcinoma/veterinary , Carcinoma, Ductal, Breast/veterinary , Deer , Intestinal Neoplasms/veterinary , Mammary Neoplasms, Animal/pathology , Neoplasms, Multiple Primary/veterinary , Adenocarcinoma/pathology , Animals , Autopsy/veterinary , Carcinoma in Situ/pathology , Carcinoma in Situ/veterinary , Carcinoma, Ductal, Breast/pathology , Euthanasia, Animal , Fatal Outcome , Female , Intestinal Neoplasms/pathology , Ireland , Lymphatic Metastasis/pathology , Neoplasms, Multiple Primary/pathologyABSTRACT
Microscopic patterns of thirty-four urothelial tumors of the urinary bladder of water buffaloes from the Marmara and Black Sea Regions of Turkey are here described. All the animals grazed on lands rich in bracken fern. Histological diagnosis was assessed using morphological parameters recently suggested for the urinary bladder tumors of cattle. Papillary carcinoma was the most common neoplastic lesion (22/34) observed in this study, and low-grade carcinoma was more common (seventeen cases) than high-grade carcinoma (five cases). Papilloma, papillary urothelial neoplasm of low malignant potential (PUNLMP), and invasive carcinomas were less frequently seen. Carcinoma in situ (CIS) was often detected associated with some papillary and invasive carcinomas. De novo (primary) CIS was rare representing 3% of tumors of this series. A peculiar feature of the most urothelial tumors was the presence in the tumor stroma of immune cells anatomically organized in tertiary lymphoid organs (TLOs). Bovine papillomavirus type-2 (PV-2) E5 oncoprotein was detected by molecular and immunohistochemistry procedures. Early protein, E2, and late protein, L1, were also detected by immunohistochemical studies. Morphological and molecular findings show that BPV-2 infection contributes to the development of urothelial bladder carcinogenesis also in water buffaloes.
Subject(s)
Bovine papillomavirus 1/physiology , Buffaloes/virology , Papillomavirus Infections/veterinary , Urinary Bladder/pathology , Urinary Bladder/virology , Urothelium/pathology , Urothelium/virology , Animals , Carcinoma in Situ/pathology , Carcinoma in Situ/veterinary , Carcinoma in Situ/virology , Cattle , DNA, Complementary/genetics , DNA, Viral/genetics , DNA, Viral/isolation & purification , Immunohistochemistry , Lymphocytes/pathology , Male , Papillomavirus Infections/pathology , Papillomavirus Infections/virologyABSTRACT
Equine penile papillomas, in situ carcinomas, and invasive carcinomas are hypothesized to belong to a continuum of papillomavirus-induced diseases. The former ones clinically present as small grey papules, while the latter 2 lesions are more hyperplasic or alternatively ulcerated. To test the hypothesis that these lesions are papillomavirus-induced, samples of 24 horses with characteristic clinical and histologic findings of penile papillomas or in situ or invasive squamous cell carcinomas were collected. As controls, 11 horses with various lesions--namely, Balanoposthitis (6 cases), melanoma (3 cases), follicular cyst (1 case), and amyloidosis (1 case)--were included. DNA was extracted and polymerase chain reaction applied to amplify papillomavirus DNA. The respective primers were designed to amplify DNA of the recently discovered equine papillomavirus EcPV2. All tested papilloma and squamous cell carcinoma samples were found to contain DNA of either of 2 previously published EcPV2 variants. Among the other samples 6 of 11 were found to contain EcPV2 DNA. To further support the findings and to determine where the papillomavirus DNA was located within the lesions, an in situ hybridization for the detection of EcPV2 DNA was established. The samples tested by this technique were found to clearly contain papillomavirus nucleic acid concentrated in the nucleus of the koilocytes. The findings of this study support previous data and the hypothesis that papillomaviruses induce the described penile lesions in horses.
Subject(s)
Carcinoma in Situ/veterinary , Carcinoma, Squamous Cell/veterinary , Horse Diseases/virology , Papilloma/veterinary , Papillomavirus Infections/veterinary , Penile Neoplasms/veterinary , Animals , Carcinoma in Situ/pathology , Carcinoma in Situ/virology , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/virology , DNA, Viral/genetics , Horse Diseases/pathology , Horses , In Situ Hybridization/veterinary , Male , Papilloma/pathology , Papilloma/virology , Papillomaviridae/genetics , Papillomaviridae/isolation & purification , Papillomavirus Infections/pathology , Papillomavirus Infections/virology , Penile Neoplasms/pathology , Penile Neoplasms/virology , Penis/pathology , Penis/virology , Polymerase Chain Reaction/veterinary , Sequence Analysis, DNA/veterinaryABSTRACT
CASE DESCRIPTION: A 12-year-old castrated male Labrador Retriever was evaluated for clinical signs associated with colorectal obstruction. CLINICAL FINDINGS: The dog had a 2-week history of tenesmus and hematochezia. On rectal examination, an annular colorectal mass was palpable extending orad into the pelvic canal. The original diagnosis of the colorectal mass was a mucosal adenoma. The dog was maintained on a low-residue diet and fecal softeners for a period of 13 months after initial diagnosis. At that time, medical management was no longer effective. TREATMENT AND OUTCOME: Placement of a colonic stent was chosen to palliate the clinical signs associated with colorectal obstruction. By use of fluoroscopic and colonoscopic guidance, a nitinol stent was placed intraluminally to open the obstructed region. Placement of the stent resulted in improvement of clinical signs, although tenesmus and obstipation occurred periodically after stent placement. At 212 days after stent placement, the patient had extensive improvement in clinical signs with minimal complications; however, clinical signs became severe at 238 days after stent placement, and the dog was euthanized. Histologic evaluation of the rectal tumor from samples obtained during necropsy revealed that the tumor had undergone malignant transformation to a carcinoma in situ. CLINICAL RELEVANCE: A stent was successfully placed in the colon and rectum to relieve obstruction associated with a tumor originally diagnosed as a benign neoplasm. Placement of colorectal stents may be an option for the palliation of colorectal obstruction secondary to neoplastic disease; however, clinical signs may persist, and continuation of medical management may be necessary.
Subject(s)
Alloys/pharmacology , Colorectal Neoplasms/veterinary , Dog Diseases/surgery , Intestinal Obstruction/veterinary , Stents/veterinary , Animals , Carcinoma in Situ/complications , Carcinoma in Situ/therapy , Carcinoma in Situ/veterinary , Colorectal Neoplasms/complications , Dog Diseases/etiology , Dogs , Intestinal Obstruction/etiology , Intestinal Obstruction/therapy , Male , Palliative CareABSTRACT
Invasive lobular carcinoma (ILC) represents 15% of invasive human breast tumours. This report describes the morphological and immunohistochemical features of three canine mammary tumours comparable with human ILC. These tumours were composed of a non-delimited proliferation of discrete cells infiltrating fibrous connective tissue. Multifocal in-situ carcinoma associated with invasive lesions was present. Invasive tumour cells and in-situ lesions expressed cytokeratin and CK34betaE12, but not E-cadherin. Based on these morphological and immunohistochemical characteristics, the tumours were classified as canine ILC.
Subject(s)
Carcinoma in Situ/veterinary , Carcinoma, Lobular/veterinary , Dog Diseases/pathology , Mammary Glands, Animal/pathology , Mammary Neoplasms, Animal/pathology , Animals , Biomarkers, Tumor/metabolism , Carcinoma in Situ/metabolism , Carcinoma in Situ/pathology , Carcinoma, Lobular/metabolism , Carcinoma, Lobular/secondary , Dog Diseases/metabolism , Dogs , Female , Keratins/metabolism , Mammary Glands, Animal/metabolism , Mammary Neoplasms, Animal/metabolism , Mastectomy/veterinary , Neoplasm InvasivenessABSTRACT
The aetiopathogenesis of urinary bladder tumours in cattle involves prolonged ingestion of bracken fern and infection by bovine papillomavirus types 1 or 2 (BPV-1/2). The oncogenic activity of BPV is largely associated with the major oncoprotein E5. Gap junctions are the only communicating junctions found in animal tissues and are composed of proteins known as connexins. Alterations in connexin expression have been associated with oncogenesis. The present study investigated biochemically and immunohistochemically the expression of connexin 43 in samples of normal (n=2), dysplastic (n=3) and neoplastic (n=23) bovine urothelium. The tumours included 10 carcinomas in situ, five papillary urothelial carcinomas and eight invasive urothelial carcinomas. Normal and dysplastic urothelium had membrane expression of connexin 43, but this was reduced in samples of carcinoma in situ. Papillary urothelial carcinomas showed moderate cytoplasmic and membrane labelling, while invasive carcinoma showed loss of connexin 43 expression.
Subject(s)
Carcinoma in Situ/veterinary , Carcinoma, Transitional Cell/veterinary , Cattle Diseases/metabolism , Connexin 43/metabolism , Urinary Bladder Neoplasms/veterinary , Animals , Biomarkers, Tumor/metabolism , Carcinoma in Situ/metabolism , Carcinoma in Situ/pathology , Carcinoma, Transitional Cell/metabolism , Carcinoma, Transitional Cell/pathology , Cattle , Cattle Diseases/pathology , Hematuria/etiology , Hematuria/pathology , Hematuria/veterinary , Oncogene Proteins, Viral/genetics , Oncogene Proteins, Viral/metabolism , Papillomaviridae/genetics , Papillomaviridae/isolation & purification , Papillomavirus Infections/pathology , Papillomavirus Infections/veterinary , Plant Poisoning/complications , Plant Poisoning/pathology , Plant Poisoning/veterinary , Plants, Toxic/poisoning , Pteridium/poisoning , Urinary Bladder Neoplasms/metabolism , Urinary Bladder Neoplasms/pathology , Urothelium/metabolism , Urothelium/pathologySubject(s)
Carcinoma in Situ/veterinary , Genital Neoplasms, Female/veterinary , Genital Neoplasms, Male/veterinary , Sea Lions , Animals , Carcinoma/pathology , Carcinoma/veterinary , Carcinoma in Situ/pathology , Female , Genital Neoplasms, Female/pathology , Genital Neoplasms, Male/pathology , Male , Urogenital Neoplasms/etiology , Urogenital Neoplasms/pathology , Urogenital Neoplasms/veterinaryABSTRACT
Mammary intraepithelial lesions (IELs) are noninvasive epithelial proliferations that include ductal hyperplasia (DH), atypical DH (ADH), and ductal carcinoma in situ (DCIS). In women, IELs are associated with increased risk of invasive breast cancer and form a basis for therapeutic decisions. Similarly, in female dogs, IELs are common in tumor-bearing glands and in non-tumor-bearing glands. To determine the prevalence and types of spontaneous IELs, mammary glands from 108 female dogs without clinical mammary disease were evaluated histologically and immunohistochemically. Within this population, 56 dogs (52%) had at least one type of spontaneous IEL, including DH (49 dogs), ADH (14 dogs), low-grade DCIS (19 dogs), intermediate-grade DCIS (12 dogs), and high-grade DCIS (1 dog). Twenty-one dogs had two or more different IEL types. In 23 of 24 dogs with atypical IELs (ADH or DCIS), immunohistochemical expression was determined for estrogen receptor alpha (ER-alpha), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER-2/neu), and Ki-67. For all markers examined, low-grade DCIS had significantly lower scores than did adjacent nonlesional gland; PR expression was significantly decreased in low-grade DCIS compared to other atypical lesions. Sixty-one lesions were ER-alpha negative (12 ADH, 36 low-grade DCIS, 13 intermediate-grade DCIS), and no lesions overexpressed HER-2/neu. Based on the dog's prevalence of spontaneous mammary IELs that precede clinical mammary disease, the remarkable histologic similarity between canine and human IELs, and the loss of ER expression in certain IELs in both species, the dog shows promise as a model for human breast preneoplasia.
Subject(s)
Carcinoma in Situ/veterinary , Dog Diseases/pathology , Animals , Biomarkers, Tumor/metabolism , Carcinoma in Situ/classification , Carcinoma in Situ/metabolism , Carcinoma in Situ/pathology , Cross-Sectional Studies , Dog Diseases/classification , Dog Diseases/metabolism , Dogs , Estrogen Receptor alpha/metabolism , Female , Immunohistochemistry/veterinary , Ki-67 Antigen/metabolism , Receptor, ErbB-2/metabolism , Receptors, Progesterone/metabolism , Statistics, NonparametricABSTRACT
Four hundred bovine urothelial tumours and tumour-like lesions were classified in accordance with the 2004 World Health Organization (WHO) morphological classification for human urothelial tumours. The spectrum of neoplastic lesions of the urinary bladder of cattle is becoming wider and bovine urothelial tumours share striking morphological features with their human counterparts. A classification system based on the WHO scheme would also be appropriate for the classification of bovine bladder tumours. Bovine urothelial tumours are most often multiple. Four distinct growth patterns of bovine urothelial tumours and tumour-like lesions are recognized: flat, exophytic or papillary, endophytic and invasive. Carcinoma in situ (CIS) is the most common flat urothelial lesion, accounting for approximately 4% of urothelial tumours. CIS is detected adjacent to papillary and invasive tumours in 80-90% of cases. Approximately 3% of papillary lesions are papillomas and approximately 5% are 'papillary urothelial neoplasms of low malignant potential' (PUNLMP). Low-grade carcinoma is the most common urothelial tumour of cattle. High-grade carcinomas, and low and high-grade invasive tumours, are less commonly seen. Bovine papillomavirus (BPV) infection and ingestion of bracken fern both play a central role in carcinogenesis of these lesions.
Subject(s)
Carcinoma in Situ/veterinary , Carcinoma, Papillary/veterinary , Cattle Diseases , Papilloma/veterinary , Urinary Bladder Neoplasms/veterinary , Urothelium/pathology , Animals , Carcinoma in Situ/pathology , Carcinoma, Papillary/pathology , Cattle , Papilloma/pathology , Urinary Bladder Neoplasms/pathologyABSTRACT
OBJECTIVE: To investigate whether cyclooxygenase-2 (COX-2) is expressed by equine ocular and adnexal squamous cell carcinomas (SCC). METHODS: Forty-three samples of histologically confirmed cases of ocular SCC or carcinoma in situ (CIS) from 34 horses presented to the Animal Health Trust between 1992 and 2004 were subjected to a standard, two-layered, indirect immunohistochemical method using a rabbit polyclonal antihuman COX-2 antibody. Ten formalin-fixed, paraffin-embedded tissue samples taken from recognized predilection sites for SCC, from the grossly normal eyes of 10 horses euthanized for reasons unrelated to this study, were used as negative controls. Samples of equine fetal kidney were used as positive controls. Following immunolabeling, the number of normal and neoplastic epithelial cells exhibiting positive COX-2 expression was recorded along with staining intensity and distribution. RESULTS: Of 43 tumors, 34 were defined as first presentation tumors. When compared with control tissue, in which 0% (0/10) of samples expressed COX-2, significantly more of these samples with SCC (58.6%, 17/29: P = 0.002), CIS (60%, 3/5: P = 0.022) or either tumor type (58.8%, 20/34: P = 0.001) exhibited positive cytoplasmic and perinuclear immunohistochemical staining for COX-2. Of the samples exhibiting positive immunohistochemical staining, only 10% (2/20) showed staining in 2%-10% of neoplastic cells, while 90% (18/20) showed staining in 1% of neoplastic cells. About 70% (14/20) of those positively immunolabeled samples exhibited an intensity of staining greater than or equal to the staining exhibited by the equine fetal kidney positive control. CONCLUSION: Neoplastic tissue from both equine ocular SCC and CIS exhibit COX-2 expression at significantly higher levels than normal control ocular tissue. However, the percentage of cells expressing positive immunohistochemical staining is consistently low. On the basis of this study, it is unlikely that anti-COX-2 therapy would be of benefit in the treatment of equine ocular and adnexal SCC.
Subject(s)
Carcinoma in Situ/veterinary , Carcinoma, Squamous Cell/veterinary , Cyclooxygenase 2/metabolism , Eye Neoplasms/veterinary , Horse Diseases/enzymology , Animals , Carcinoma in Situ/enzymology , Carcinoma, Squamous Cell/enzymology , Case-Control Studies , Cyclooxygenase 2/genetics , Eye Neoplasms/enzymology , Female , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Horses , Immunohistochemistry/veterinary , MaleABSTRACT
Multicentric squamous cell carcinoma in situ (MSCCIS) is a variant of squamous cell carcinoma in cats, commonly referred to as Bowen's-like disease. Imiquimod 5% cream (Aldara) is a novel immune response modifier (IRM) that has been reported as a successful treatment for Bowen's disease in humans. The purpose of this study was to describe clinical findings, treatment protocols and survival in cats with MSCCIS treated with imiquimod 5% cream and to examine the effects of imiquimod 5% cream in cats with MSCCIS. The expression of papillomavirus group-specific antigen in the study population was also determined. From review of medical records, 12 cats were identified with a histologic diagnosis of MSCCIS and treatment with imiquimod 5% cream. Initial lesions responded to imiquimod 5% cream in all cats. Most cats (75%) developed new lesions. New lesions also responded to imiquimod 5% cream in all cats treated. Five cats (41%) had side effects suspected to be associated with the use of imiquimod 5% cream, including local erythema (25%), increased liver enzymes and neutropenia (8%), and partial anorexia and vomiting (8%). Kaplan-Meier median treatment duration and median survival time probabilities for cats in this study were 1189 days, respectively. A time to failure model was generated as many cats were censored from analysis well before the aforementioned projected median. This model resulted in a shorter median survival time of 243 days. No patient-related, tumour-related or treatment-related prognostic variables were identified. No expression for papilloma group-specific antigen was found. Imiquimod 5% cream appears to be well tolerated in the majority of cats, and further studies are warranted to further examine its usefulness in cats with this disease.
Subject(s)
Aminoquinolines/therapeutic use , Antineoplastic Agents/therapeutic use , Carcinoma in Situ/veterinary , Carcinoma, Squamous Cell/veterinary , Cat Diseases/drug therapy , Skin Neoplasms/veterinary , Animals , Bowen's Disease/drug therapy , Bowen's Disease/mortality , Bowen's Disease/veterinary , Carcinoma in Situ/drug therapy , Carcinoma in Situ/mortality , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/mortality , Cat Diseases/mortality , Cats , Female , Imiquimod , Kaplan-Meier Estimate , Male , Neoplasm Recurrence, Local/drug therapy , Neoplasm Recurrence, Local/veterinary , Skin Neoplasms/drug therapy , Skin Neoplasms/mortality , Treatment OutcomeABSTRACT
Mammary intraepithelial lesions (IEL) are nowadays frequently diagnosed as a result of the success of mammographic screening, education programs, and awareness by women. Establishment of an animal model for these lesions to test treatment or preventive modalities is a prerequisite for human clinical trials. A model for spontaneous IELs, especially for estrogen receptor (ER)-negative lesions, does not exist. This study describes the histologic and immunohistochemical similarity between human and canine mammary IELs. Mammary tumors from 200 dogs were classified and histologic sections of the excisional specimens were evaluated for IELs. IELs, found in specimens from 60 dogs, were categorized as adenosis, sclerosing adenosis, intraductal papilloma, sclerosing papilloma, ductal hyperplasia, atypical ductal hyperplasia (ADH), and ductal carcinoma in situ (DCIS; high, intermediate, and low grade). Most proliferative IELs without atypia were associated with benign tumors, whereas IELs with atypia (ADH and DCIS) were generally associated with mammary cancer. ER-alpha expression was significantly low or absent in most ADH and DCIS lesions as well as in their associated tumors. Ki67 expression was significantly higher in high-grade DCIS than in hyperplasia or low-grade DCIS. Two thirds of high-grade DCIS lesions were positive for HER-2. Canine mammary IELs were strikingly similar to those of the human breast. The frequency of IELs in the dog, their association with spontaneous mammary cancer, their pattern of ER-alpha and HER-2 expression, and their histologic resemblance to human IELs may make the dog an ideal model to study human ER-negative (both HER-2 positive and negative) breast cancer progression as well as prevention and treatment.
Subject(s)
Breast Neoplasms/pathology , Carcinoma in Situ/pathology , Carcinoma in Situ/veterinary , Dog Diseases/pathology , Mammary Neoplasms, Animal/pathology , Animals , Breast Neoplasms/metabolism , Carcinoma in Situ/metabolism , Carcinoma, Intraductal, Noninfiltrating/metabolism , Carcinoma, Intraductal, Noninfiltrating/pathology , Disease Models, Animal , Dog Diseases/metabolism , Dogs , Estrogen Receptor alpha/biosynthesis , Female , Humans , Immunohistochemistry , Ki-67 Antigen/biosynthesis , Mammary Neoplasms, Animal/metabolism , Receptor, ErbB-2/biosynthesis , Receptors, Progesterone/biosynthesisABSTRACT
In the light of earlier human studies, 43 canine tumours diagnosed as seminoma were examined histologically with haematoxylin and eosin and periodic acid-Schiff (PAS) stains, and immunohistochemically with a monoclonal antibody against human placental alkaline phosphatase (PLAP). Twenty tumours were positive for both PAS and PLAP and were therefore diagnosed as classical seminoma (SE). The other 23 tumours were negative for both PAS and PLAP and were therefore diagnosed as spermatocytic seminoma (SS). Tubules with carcinoma in situ (CIS) were present in the testicular parenchyma surrounding 15 SEs and nine SSs.